Similarly, differences exist in the source of PD-L1 quantification, whether accounting for PD-L1 on tumor cells only (tumor proportion score- TPS) or its expression on tumor cells, lymphocytes, and macrophages from the tumor microenvironment (CPS: combined positive score) [138,139]. This evidence concerns the gene CD274 and neoplasm.